動力源(600405.SH):中標約2.23億元的中國移動相關集採項目
格隆匯9月16日丨動力源(600405.SH)公佈,公司於2021年9月16日收到北京煜金橋通信建設監理諮詢有限責任公司2021年9月14日簽發的《中標通知書》,公司被確定為中國移動2021年至2023年組合式開關電源產品集中採購項目的中標單位。
中標份額為27.78%(公司投標報價為801,664,398.88元(不含税)),預計的中標金額為222,702,370.01元(不含税)。
此次中國移動集採項目公司中標,對公司通信電源產品進一步拓展市場起到積極作用。如果中標項目得以順利實施,預計將對公司2021年至2023年經營業績產生積極影響,有利於提升公司整體盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.